NO981135L - Syreaddisjonssalter av 2,3,4,5-tetrahydro-1H-3-benzazepinforbindelser - Google Patents
Syreaddisjonssalter av 2,3,4,5-tetrahydro-1H-3-benzazepinforbindelserInfo
- Publication number
- NO981135L NO981135L NO981135A NO981135A NO981135L NO 981135 L NO981135 L NO 981135L NO 981135 A NO981135 A NO 981135A NO 981135 A NO981135 A NO 981135A NO 981135 L NO981135 L NO 981135L
- Authority
- NO
- Norway
- Prior art keywords
- tetrahydro
- acid addition
- addition salts
- benzazepine compounds
- benzazepine
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 2
- MWVMYAWMFTVYED-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-3-benzazepine Chemical class C1CNCCC2=CC=CC=C21 MWVMYAWMFTVYED-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- XTBPVXNRDRWQNN-ZDUSSCGKSA-N (5s)-8-chloro-5-(5,6-dichloro-2,3-dihydro-1-benzofuran-7-yl)-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol Chemical class C1N(C)CCC2=CC(Cl)=C(O)C=C2[C@H]1C1=C(OCC2)C2=CC(Cl)=C1Cl XTBPVXNRDRWQNN-ZDUSSCGKSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK103095 | 1995-09-15 | ||
| PCT/DK1996/000383 WO1997010239A1 (en) | 1995-09-15 | 1996-09-12 | Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO981135D0 NO981135D0 (no) | 1998-03-13 |
| NO981135L true NO981135L (no) | 1998-03-13 |
Family
ID=8100205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO981135A NO981135L (no) | 1995-09-15 | 1998-03-13 | Syreaddisjonssalter av 2,3,4,5-tetrahydro-1H-3-benzazepinforbindelser |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0850237A1 (cs) |
| JP (1) | JPH11512403A (cs) |
| KR (1) | KR19990044648A (cs) |
| CN (1) | CN1200121A (cs) |
| AU (1) | AU700596B2 (cs) |
| BR (1) | BR9610162A (cs) |
| CA (1) | CA2231848A1 (cs) |
| CZ (1) | CZ77898A3 (cs) |
| HU (1) | HUP9900746A3 (cs) |
| IL (1) | IL123602A0 (cs) |
| NO (1) | NO981135L (cs) |
| PL (1) | PL325514A1 (cs) |
| WO (1) | WO1997010239A1 (cs) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK23392D0 (da) * | 1992-02-24 | 1992-02-24 | Novo Nordisk As | Heterocykliske forbindelser, deres anvendelse og fremstilling |
-
1996
- 1996-09-12 BR BR9610162A patent/BR9610162A/pt unknown
- 1996-09-12 JP JP9511574A patent/JPH11512403A/ja active Pending
- 1996-09-12 CZ CZ98778A patent/CZ77898A3/cs unknown
- 1996-09-12 HU HU9900746A patent/HUP9900746A3/hu unknown
- 1996-09-12 AU AU69235/96A patent/AU700596B2/en not_active Ceased
- 1996-09-12 CN CN96197660A patent/CN1200121A/zh active Pending
- 1996-09-12 WO PCT/DK1996/000383 patent/WO1997010239A1/en not_active Application Discontinuation
- 1996-09-12 KR KR1019980701902A patent/KR19990044648A/ko not_active Withdrawn
- 1996-09-12 IL IL12360296A patent/IL123602A0/xx unknown
- 1996-09-12 PL PL96325514A patent/PL325514A1/xx unknown
- 1996-09-12 EP EP96930028A patent/EP0850237A1/en not_active Withdrawn
- 1996-09-12 CA CA002231848A patent/CA2231848A1/en not_active Abandoned
-
1998
- 1998-03-13 NO NO981135A patent/NO981135L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11512403A (ja) | 1999-10-26 |
| CZ77898A3 (cs) | 1998-07-15 |
| HUP9900746A3 (en) | 1999-11-29 |
| MX9802000A (es) | 1998-08-30 |
| EP0850237A1 (en) | 1998-07-01 |
| CN1200121A (zh) | 1998-11-25 |
| PL325514A1 (en) | 1998-08-03 |
| WO1997010239A1 (en) | 1997-03-20 |
| NO981135D0 (no) | 1998-03-13 |
| AU700596B2 (en) | 1999-01-07 |
| AU6923596A (en) | 1997-04-01 |
| HUP9900746A2 (hu) | 1999-09-28 |
| KR19990044648A (ko) | 1999-06-25 |
| CA2231848A1 (en) | 1997-03-20 |
| BR9610162A (pt) | 1999-01-05 |
| IL123602A0 (en) | 1998-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9605741A (es) | Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano. | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| SE9504661D0 (sv) | New compounds | |
| BG102259A (en) | Compostions with controlled paroxetine release | |
| AU5313496A (en) | Nodulisporic acid derivatives | |
| AP2000001947A0 (en) | Novel crystalline forms of an antiviral benzidazole compound. | |
| BR0014651A (pt) | Inibidores de adesão de célula mediada por "alfa" l beta2 | |
| NO996108L (no) | 9-oksinerytromycinderivater | |
| PT998287E (pt) | Utilizacao de levobupivacaina | |
| NO975975L (no) | Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav | |
| ATE201680T1 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze | |
| DK0744397T3 (da) | Fluorphenylsubstituerede alkenylcarboxylsyre-guanidiner som Na+/K+-antiport-inhibitorer, deres anvendelse som lægemiddel el | |
| NO964348L (no) | CCK- eller gastrin-modulerende 5-hetrocykliske-1,5-benzodiazepiner | |
| TR199900730T2 (xx) | S�v� alendronat form�lasyonlar� | |
| SE9504662D0 (sv) | New compounds | |
| EP1008345A4 (en) | ANTI-ALLERGIC AGENTS | |
| IT1306147B1 (it) | Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali | |
| NO981135L (no) | Syreaddisjonssalter av 2,3,4,5-tetrahydro-1H-3-benzazepinforbindelser | |
| ES2170377T3 (es) | Composicion que contiene quitosana. | |
| BG103779A (en) | Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid | |
| BR9712805A (pt) | Processo para a preparação de compostos farmecêuticos | |
| KR960700053A (ko) | 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer) | |
| DK0967986T3 (da) | Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat |